Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29650963.
- Also identified by DOI 10.1038/s41467-018-03704-z and PMC identifier 5897363.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The chronic skin inflammation psoriasis is crucially dependent on the IL-23/IL-17 cytokine axis. Although IL-23 is expressed by psoriatic keratinocytes and immune cells, only the immune cell-derived IL-23 is believed to be disease relevant. Here we use a genetic mouse model to show that keratinocyte-produced IL-23 is sufficient to cause a chronic skin inflammation with an IL-17 profile. Furthermore, we reveal a cell-autonomous nuclear function for the actin polymerizing molecule N-WASP, which controls IL-23 expression in keratinocytes by regulating the degradation of the histone methyltransferases G9a and GLP, and H3K9 dimethylation of the IL-23 promoter. This mechanism mediates the induction of IL-23 by TNF, a known inducer of IL-23 in psoriasis. Finally, in keratinocytes of psoriatic lesions a decrease in H3K9 dimethylation correlates with increased IL-23 expression, suggesting relevance for disease. Taken together, our data describe a molecular pathway where epigenetic regulation of keratinocytes can contribute to chronic skin inflammation.
Medical subject headings
- Epigenesis, Genetic
- Histone-Lysine N-Methyltransferase
- Interleukin-23 Subunit p19
- Psoriasis
- Skin
- Wiskott-Aldrich Syndrome Protein, Neuronal